VRX - Valeant Pharmaceuticals International, Inc.

NYSE - NYSE Delayed Price. Currency in USD
Currency in USD
Earnings EstimateCurrent Qtr. (Sep 2010)Next Qtr. (Dec 2010)Current Year (2010)Next Year (2011)
No. of Analysts0000
Avg. Estimate0000
Low Estimate0000
High Estimate0000
Year Ago EPS0.580.67N/AN/A
Revenue EstimateCurrent Qtr. (Sep 2010)Next Qtr. (Dec 2010)Current Year (2010)Next Year (2011)
No. of Analysts5566
Avg. Estimate297.08M307.13M1.09B1.26B
Low Estimate270.8M288.9M1.05B1.14B
High Estimate333M331.7M1.15B1.4B
Year Ago Sales220.32M240.52M830.46M1.09B
Sales Growth (year/est)34.80%27.70%30.90%15.60%
Earnings History9/29/200912/30/20093/30/20106/29/2010
EPS Est.0.490.590.590.63
EPS Actual0.580.670.640.69
Difference0.090.080.050.06
Surprise %18.40%13.60%8.50%9.50%
EPS TrendCurrent Qtr. (Sep 2010)Next Qtr. (Dec 2010)Current Year (2010)Next Year (2011)
Current Estimate0000
7 Days Ago0.810.822.943.34
30 Days Ago0.810.822.943.34
60 Days Ago0.810.822.943.34
90 Days Ago0.810.822.943.34
EPS RevisionsCurrent Qtr. (Sep 2010)Next Qtr. (Dec 2010)Current Year (2010)Next Year (2011)
Up Last 7 DaysN/AN/AN/AN/A
Up Last 30 DaysN/AN/AN/AN/A
Down Last 30 DaysN/AN/AN/AN/A
Down Last 90 DaysN/AN/AN/AN/A
Growth EstimatesVRXIndustrySectorS&P 500
Current Qtr.N/AN/A-1.000.15
Next Qtr.N/AN/A-1.000.27
Current YearN/AN/AN/A0.07
Next YearN/AN/AN/A0.12
Next 5 Years (per annum)15.24%N/A0.150.10
Past 5 Years (per annum)61.43%N/AN/AN/A